<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Liang, Xiujie</dc:creator>
  <dc:creator>Arullampalam, Prakash</dc:creator>
  <dc:creator>Yang, Zhihong</dc:creator>
  <dc:creator>Ming, Xiu-Fen</dc:creator>
  <dc:date>2019-08-14</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Hypoxia plays a crucial role in the pathogenesis of cardiovascular diseases.  Mitochondrial enzyme arginase type II (Arg-II) is reported to lead to endothelial  dysfunction and enhance the expression of endothelial inflammatory adhesion  molecules such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell  adhesion molecule-1 (VCAM-1). In this study, we investigate the role of Arg-II in  hypoxia-induced endothelial activation and the potential underlying mechanisms.  Exposure of the human endothelial cells to hypoxia induced a time-dependent  increase in Arg-II, HIF1α, HIF2α, and ICAM-1 protein level, whereas no change in the  protein level of VCAM-1 and E-selectin was observed. Similar effects were obtained in  cells treated with a hypoxia mimetic Dimethyloxaloylglycine (DMOG). Silencing HIF1α,  but not HIF2α, reversed hypoxia-induced upregulation of Arg-II. Moreover, silencing  Arg-II prevented the ICAM-1 upregulation induced by hypoxia or DMOG. Furthermore,  the endothelial cells incubated under hypoxic condition or treated with DMOG or  hypoxia enhanced monocyte adhesion, which was inhibited by silencing Arg-II. Lastly,  silencing Arg-II prevented hypoxia-induced mitochondrial superoxide production in  endothelial cells, and hypoxia-induced ICAM-1 upregulation was reversed by  mitochondrial electron transport inhibitor rotenone. These data demonstrate that  hypoxia enhances ICAM-1 protein level and monocyte-endothelial interaction through  HIF1α-mediated increase in Arg-II protein level on leading to increased mitochondrial  reactive oxygen species production. These effects of hypoxia on endothelial cells may  play a key role in cardiovascular diseases. Our results suggest that Arg-II could be a  promising therapeutic target to prevent hypoxia-induced vascular  damage/dysfunction.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/308093</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/308093/files/yan_hee.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3389/fphys.2019.01003</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Frontiers in Physiology. - 2019, vol. 10, p. 1003</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Hypoxia enhances endothelial intercellular adhesion molecule 1 protein level through upregulation of arginase type II and mitochondrial oxidative stress</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
